Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claes Held

Showing results (101-110 of 227) with videos related to

Pageof 23
Sort By:
Platelets|October 17, 2013
Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO studyRobert F Storey, Stefan K James, Agneta Siegbahn, et al.
International Journal of Cardiology|September 11, 2022
Organizational and patient-level predictors for attaining key risk factor targets in cardiac rehabilitation after myocardial infarction: The Perfect-CR studyHalldora Ögmundsdottir Michelsen, Peter Henriksson, John Wallert, et al.
Heart (British Cardiac Society)|June 25, 2014
Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromesChristoph Varenhorst, Ulrica Alström, Oscar Ö Braun, et al.
Heart (British Cardiac Society)|November 1, 2016
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillationM Cecilia Bahit, Renato D Lopes, Daniel M Wojdyla, et al.
Plos Medicine|January 13, 2021
Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective studyLars Wallentin, Niclas Eriksson, Maciej Olszowka, et al.
Heart (British Cardiac Society)|January 21, 2018
Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve diseaseDragos Vinereanu, Alice Wang, Hillary Mulder, et al.
Circulation. Cardiovascular Interventions|May 31, 2015
Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularizationAkshay Bagai, Zhen Huang, Yuliya Lokhnygina, et al.
Cardiovascular Research|March 4, 2023
Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular diseasePia Davidsson, Susanna Eketjäll, Niclas Eriksson, et al.
International Journal of Cardiology|October 9, 2015
Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trialMichael T Durheim, Derek D Cyr, Renato D Lopes, et al.
American Heart Journal|July 26, 2021
The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trialFelix Böhm, Brynjölfur Mogensen, Ollie Östlund, et al.
Pageof 23

Showing results (101-110 of 227) with videos related to

Sort By:
Pageof 23
Platelets|October 17, 2013
Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO studyRobert F Storey, Stefan K James, Agneta Siegbahn, et al.
International Journal of Cardiology|September 11, 2022
Organizational and patient-level predictors for attaining key risk factor targets in cardiac rehabilitation after myocardial infarction: The Perfect-CR studyHalldora Ögmundsdottir Michelsen, Peter Henriksson, John Wallert, et al.
Heart (British Cardiac Society)|June 25, 2014
Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromesChristoph Varenhorst, Ulrica Alström, Oscar Ö Braun, et al.
Heart (British Cardiac Society)|November 1, 2016
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillationM Cecilia Bahit, Renato D Lopes, Daniel M Wojdyla, et al.
Plos Medicine|January 13, 2021
Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective studyLars Wallentin, Niclas Eriksson, Maciej Olszowka, et al.
Heart (British Cardiac Society)|January 21, 2018
Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve diseaseDragos Vinereanu, Alice Wang, Hillary Mulder, et al.
Circulation. Cardiovascular Interventions|May 31, 2015
Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularizationAkshay Bagai, Zhen Huang, Yuliya Lokhnygina, et al.
Cardiovascular Research|March 4, 2023
Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular diseasePia Davidsson, Susanna Eketjäll, Niclas Eriksson, et al.
International Journal of Cardiology|October 9, 2015
Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trialMichael T Durheim, Derek D Cyr, Renato D Lopes, et al.
American Heart Journal|July 26, 2021
The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trialFelix Böhm, Brynjölfur Mogensen, Ollie Östlund, et al.
Pageof 23